Activity-Dependent Neuroprotective Protein Snippet NAP Reduces Tau Hyperphosphorylation and Enhances Learning in a Novel Transgenic Mouse Model

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/jpet.107.129551PMID 17720885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis.

  2007cited by this paper
• Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry

  2007cited by this paper
• Brain injury-dependent expression of activity-dependent neuroprotective protein

  2007cited by this paper
• Multigene deletions on chromosome 20q13.13‐q13.2 including SALL4 result in an expanded phenotype of Okihiro syndrome plus developmental delay

  2007cited by this paper
• Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage

  2007cited by this paper
• Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo

  2007cited by this paper
• The peptide NAP promotes neuronal growth and differentiation through extracellular signal‐regulated protein kinase and Akt pathways, and protects neurons co‐cultured with astrocytes damaged by ethanol

  2007cited by this paper
• Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

  2007cited by this paper
• Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures

  2007cited by this paper
• Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress.

  2006influential reference
• Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment.

  2006cited by this paper
• NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP).

  2006cited by this paper
• Impaired Glutamate Transport in a Mouse Model of Tau Pathology in Astrocytes

  2006cited by this paper
• The Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation*

  2006cited by this paper
• Peptide neuroprotection through specific interaction with brain tubulin

  2006cited by this paper
• Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After Streptozotocin-Induced Insulin Deficiency

  2006cited by this paper
• Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome.

  2005cited by this paper
• The role of stem cells in cardiac regeneration

  2005cited by this paper
• The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection

  2005cited by this paper
• Regional distribution of fluoro-jade B staining in the hippocampus following traumatic brain injury.

  2005cited by this paper
• The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury.

  2005influential reference
• Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze.

  2004cited by this paper
• Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus.

  2004cited by this paper
• A Femtomolar Acting Octapeptide Interacts with Tubulin and Protects Astrocytes against Zinc Intoxication*

  2004cited by this paper
• Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes.

  2004cited by this paper
• Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

  2004cited by this paper
• Activity-dependent neuroprotective protein: a novel gene essential for brain formation.

  2003cited by this paper
• Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses.

  2003cited by this paper
• New roles for astrocytes (stars at last).

  2003cited by this paper
• Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process

  2002cited by this paper
• Signature tau neuropathology in gray and white matter of corticobasal degeneration.

  2002cited by this paper
• Neuronal injury and loss after traumatic brain injury: time course and regional variability.

  2001cited by this paper
• Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein*

  2001cited by this paper
• Cdk5 and MAPK are associated with complexes of cytoskeletal proteins in rat brain.

  2000cited by this paper
• Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze.

  2000cited by this paper
• nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease.

  2000cited by this paper
• Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2.

  2000cited by this paper
• REVIEW: tau protein pathology in Alzheimer’s disease and related disorders

  1999cited by this paper
• Complete Sequence of a Novel Protein Containing a Femtomolar‐Activity‐Dependent Neuroprotective Peptide

  1999cited by this paper
• Cloning and characterization of the

  1996cited by this paper
• Roles of Pax-genes in developing and adult brain as suggested by expression patterns

  1994cited by this paper
• Multiple tubulin forms are expressed by a single neurone

  1981cited by this paper

• Clinical and Genetic Characterization of Patients with ADNP Related Helsmoortel-Van der Aa Syndrome.

  2026cites this paper
• A frameshift variant in activity-dependent neuroprotective protein (ADNP) causes nucleocytoskeletal alterations in a dizygotic male twin: a case study

  2025cites this paper
• Intranasal NAP (Davunetide): Neuroprotection and circadian rhythmicity.

  2025cites this paper
• Targeted tau protein degradation: a promising therapeutic approach for tauopathies.

  2025cites this paper
• Disentangling the role of tau pathology in autism spectrum disorders.

  2025cites this paper
• Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024

  2025cites this paper
• Editorial: A Child with ADNP Syndrome: A Case Study of Symptoms, Diagnostic Process and Innovative Behavioral Intervention Modes

  2025cites this paper
• The ADNP-Mediated Transcriptome Response to Ketamine Impairs the Cytoskeletal Protein Axis

  2025influential citation
• Therapeutic potential of small peptides in Alzheimer's disease: Advances in memory restoration and targeted delivery systems.

  2025cites this paper
• Neuron-targeted caveolin-1 overexpression attenuates cognitive loss and pathological transcriptome changes in symptomatic Alzheimer’s disease models

  2025cites this paper
• Systemic davunetide provides sex-specific neuroprotection during Coronary Artery Bypass Grafting (CABG)

  2025cites this paper
• Extended phenotypic characterization of a novel Helsmoortel‐van der Aa syndrome case series

  2024cites this paper
• ADNP is essential for sex-dependent hippocampal neurogenesis, through male unfolded protein response and female mitochondrial gene regulation

  2024cites this paper
• Genetic and Environmental Factors Co-Contributing to Behavioral Abnormalities in adnp/adnp2 Mutant Zebrafish

  2024cites this paper
• ADNP dysregulates methylation and mitochondrial gene expression in the cerebellum of a Helsmoortel–Van der Aa syndrome autopsy case

  2024cites this paper
• Moderate Physical Activity Increases the Expression of ADNP in Rat Brain

  2024cites this paper
• Sex-Specific ADNP/NAP (Davunetide) Regulation of Cocaine-Induced Plasticity

  2024cites this paper
• From circadian sleep disruption to Neuroprotection: The potential of VIP/PACAP in Alzheimer’s disease treatment

  2024cites this paper
• Use of biomarkers in the diagnosis of Alzheimer's disease in adults with intellectual disability.

  2024cites this paper
• Tracing the invisible mutant ADNP protein in Helsmoortel-Van der Aa syndrome patients

  2024cites this paper
• How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?

  2024cites this paper
• Protective inherited mutations in activity-dependent neuroprotective protein (ADNP): the good, the bad, and the ugly

  2024cites this paper
• A guide to selecting high-performing antibodies for ADNP (UniProt ID: Q9H2P0) for use in western blot, immunoprecipitation, and immunofluorescence

  2024cites this paper
• NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms

  2023cites this paper
• Tau, ADNP, and sex

  2023influential citation
• Microtubule stabilising peptides: new paradigm towards management of neuronal disorders.

  2023cites this paper
• Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women

  2023cites this paper
• Natural plant materials as a source of neuroprotective peptides.

  2023cites this paper
• The cytoplasmic localization of ADNP through 14-3-3 promotes sex-dependent neuronal morphogenesis, cortical connectivity, and calcium signaling

  2023influential citation
• Adnp-mutant mice with cognitive inflexibility, CaMKIIα hyperactivity, and synaptic plasticity deficits

  2023cites this paper
• Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism

  2023influential citation
• DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients

  2022cites this paper
• A convergent mechanism of high risk factors ADNP and POGZ in neurodevelopmental disorders.

  2022cites this paper
• SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism

  2022cites this paper
• Effects of paternal methionine supplementation on sperm DNA methylation and embryo transcriptome in sheep

  2022cites this paper
• Modelling Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) Using Mice and Zebrafish

  2022cites this paper
• Avian models for brain mechanisms underlying altered social behavior in autism

  2022cites this paper
• Somatic Mutations and Alzheimer’s Disease

  2022cites this paper
• Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development

  2022cites this paper
• An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome

  2022cites this paper
• Activity-Dependent Neuroprotective Protein (ADNP): An Overview of Its Role in the Eye

  2022influential citation
• Distinct Impairments Characterizing Different ADNP Mutants Reveal Aberrant Cytoplasmic-Nuclear Crosstalk

  2022cites this paper
• Improving replicability using interaction with laboratories: a multi-lab experimental assessment

  2021cites this paper
• Proteomics of autism and Alzheimer’s mouse models reveal common alterations in mTOR signaling pathway

  2021cites this paper
• Introducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation

  2021cites this paper
• Reciprocal control of translation and transcription in autism spectrum disorder

  2021cites this paper
• Parkinson Disease-Modification Encompassing Rotenone and 6-Hydroxydopamine Neurotoxicity by the Microtubule-Protecting Drug Candidate SKIP

  2021cites this paper
• A critical appraisal of tau‐targeting therapies for primary and secondary tauopathies

  2021cites this paper
• Exposure to sevoflurane results in changes of transcription factor occupancy in sperm and inheritance of autism

  2021cites this paper
• Utilizing an Animal Model to Identify Brain Neurodegeneration-Related Biomarkers in Aging

  2021cites this paper
• Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration

  2021cites this paper
• Novel ADNP Syndrome Mice Reveal Dramatic Sex-Specific Peripheral Gene Expression With Brain Synaptic and Tau Pathologies.

  2021cites this paper
• Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond

  2020cites this paper
• The ADNP Syndrome and CP201 (NAP) Potential and Hope

  2020cites this paper
• Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

  2020cites this paper
• VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive in vivo and in silico Effects

  2020cites this paper
• Peptide LIQ promotes cell protection against zinc-induced cytotoxicity through microtubule stabilization.

  2020cites this paper
• Experimental Models to Study Autism Spectrum Disorders: hiPSCs, Rodents and Zebrafish

  2020cites this paper
• Activity-dependent neuroprotective protein (ADNP)/NAP (CP201): Autism, schizophrenia, and Alzheimer’s disease

  2020cites this paper
• Single Cell ADNP Predictive of Human Muscle Disorders: Mouse Knockdown Results in Muscle Wasting

  2020cites this paper
• Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.

  2020cites this paper
• Age and Sex-Dependent ADNP Regulation of Muscle Gene Expression Is Correlated with Motor Behavior: Possible Feedback Mechanism with PACAP

  2020cites this paper
• 1 14-3-3 shuttles Activity-dependent neuroprotective protein to the cytoplasm to promote 1 appropriate neuronal morphogenesis , cortical connectivity and calcium signaling

  2020influential citation
• Autophagy and Schizophrenia.

  2020cites this paper
• Episignatures Stratifying Helsmoortel-Van Der Aa Syndrome Show Modest Correlation with Phenotype.

  2020cites this paper
• Factors Related to Alzheimer’s Disease, Tau Pathology in Alzheimer’s Disease: Possible Treatments for Tau Pathology

  2020cites this paper
• Deciphering the Enigma: NAP (CP201) the Active ADNP Drug Candidate Enters Cells by Dynamin-Associated Endocytosis

  2020cites this paper
• Sex-and Region-Dependent Expression of the Autism-Linked ADNP Correlates with Social- and Speech-Related Genes in the Canary Brain

  2020cites this paper
• 14-3-3 shuttles Activity-dependent neuroprotective protein to the cytoplasm to promote appropriate neuronal morphogenesis, cortical connectivity and calcium signaling

  2020influential citation
• Targeting Tau to Treat Clinical Features of Huntington's Disease

  2020cites this paper
• Tauopathy in the young autistic brain: novel biomarker and therapeutic target

  2020cites this paper
• Episignatures stratifying ADNP syndrome show modest correlation with phenotype

  2020cites this paper
• The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse

  2019cites this paper
• Atypical Auditory Brainstem Response and Protein Expression Aberrations Related to ASD and Hearing Loss in the Adnp Haploinsufficient Mouse Brain

  2019cites this paper
• ADNP differentially interact with genes/proteins in correlation with aging: a novel marker for muscle aging

  2019cites this paper
• Cellular and animal models of skin alterations in the autism-related ADNP syndrome

  2019cites this paper
• Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings

  2019cites this paper
• The autism-mutated ADNP plays a key role in stress response

  2019cites this paper
• Dual Role of Autophagy in Diseases of the Central Nervous System

  2019cites this paper
• Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs

  2019cites this paper
• Developmental Phenotype of the Rare Case of DJ Caused by a Unique ADNP Gene De Novo Mutation

  2019cites this paper
• Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study

  2019influential citation
• Molecular causes of sex‐specific deficits in rodent models of neurodevelopmental disorders

  2019cites this paper
• Disease-modifying therapies for tauopathies: agents in the pipeline

  2019cites this paper
• Convergence of spectrums: neuronal gene network states in autism spectrum disorder.

  2019cites this paper
• Reduction of aluminum ion neurotoxicity through a small peptide application – NAP treatment of Alzheimer’s disease

  2019cites this paper
• ADNP promotes neural differentiation by modulating Wnt/β-catenin signaling

  2019cites this paper
• What we can learn from a genetic rodent model about autism.

  2019cites this paper
• A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP

  2019cites this paper
• The Role of the Microtubule Cytoskeleton in Neurodevelopmental Disorders

  2018cites this paper
• Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice

  2018influential citation
• NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies

  2018cites this paper
• Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia

  2018cites this paper
• The chromatin basis of neurodevelopmental disorders: Rethinking dysfunction along the molecular and temporal axes

  2018cites this paper
• ADNP Regulates Cognition: A Multitasking Protein

  2018influential citation
• ADNP, a Microtubule Interacting Protein, Provides Neuroprotection Through End Binding Proteins and Tau: An Amplifier Effect

  2018cites this paper
• Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome

  2018cites this paper
• Significance of heterogeneous WNT and MAPK signaling in colorectal cancer

  2017cites this paper
• ADNP Plays a Key Role in Autophagy: From Autism to Schizophrenia and Alzheimer's Disease

  2017cites this paper
• Davunetide improves spatial learning and memory in Alzheimer's disease-associated rats.

  2017cites this paper